University of Arizona

Venture capital funding for biopharmaceutical companies overall may be down in 2023, but that does not mean that investors have stopped placing big bets on the industry. Three companies announced rece

Erasca Five-Year Collaboration With MD Anderson Focused On MAPKlamp Combo Precision oncology-focused Erasca, Inc. inked a research and development collaboration on 23 August with the University of

Fully two years into the COVID-19 pandemic, biopharmaceutical companies and academic/non-profit research organizations continue to partner on efforts to prevent and combat infections by the SARS-CoV-2

Cytokinetics Inc. saw no statistically significant results on the major primary and secondary endpoints in its Phase II clinical trial of reldesemtiv in amyotrophic lateral sclerosis (ALS), but the c